Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to evaluate the effect Restasis has in regards to disease progression.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1. | Active Comparator |
| |
| 2. | Placebo Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Restasis | Drug | Restasis- (in the eye) Instill one drop twice daily Endura- (in the eye) Instill one drop twice daily |
|
| Measure | Description | Time Frame |
|---|---|---|
| Disease Severity | 1 yr |
| Measure | Description | Time Frame |
|---|---|---|
| Staining | 1 yr |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Sanjay Rao | Lakeside Eye Clinic | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Lakeside Eye Clinic | Chicago | Illinois | 60641 | United States |
Not provided
| ID | Term |
|---|---|
| D018450 | Disease Progression |
| ID | Term |
|---|---|
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D003524 | Cyclosporins |
| ID | Term |
|---|---|
| D010456 | Peptides, Cyclic |
| D047028 | Macrocyclic Compounds |
| D011083 | Polycyclic Compounds |
| D010455 | Peptides |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Endura | Drug | Restasis- (in the eye) Instill one drop twice daily Endura- (in the eye) Instill one drop twice daily |
|
| D000602 |
| Amino Acids, Peptides, and Proteins |